Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Completes Pilot Study of Gentana s Gene-mapping Tech

NEW YORK, Nov. 29 (GenomeWeb News) - Gentana said today that Monsanto has completed a pilot study of its gene-mapping technology.


In the study, Monsanto's seed business evaluated Gentana's technology for gene-expression profiling. Gentana said that Monsanto delivered "a positive report."


Thorsten Storck, COO at Gentana, told GenomeWeb News that Monsanto is currently "working on the results of the study," and that no additional agreement for his company's technology has been signed. He declined to comment further.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.